Nutex Health (NASDAQ:NUTX) Price Target Raised to $60.00

Nutex Health (NASDAQ:NUTX) had its price objective increased by equities research analysts at Benchmark from $45.00 to $60.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Benchmark’s price target suggests a potential upside of 114.98% from the stock’s current price.

Separately, Maxim Group lifted their price target on Nutex Health from $45.00 to $50.00 and gave the company a “buy” rating in a report on Tuesday.

Nutex Health Trading Down 11.6 %

NUTX stock opened at $27.91 on Tuesday. The company has a debt-to-equity ratio of 3.04, a current ratio of 1.59 and a quick ratio of 1.55. The stock has a market capitalization of $141.39 million, a price-to-earnings ratio of -2.97 and a beta of 0.11. The business has a fifty day moving average price of $22.67 and a 200 day moving average price of $13.60. Nutex Health has a fifty-two week low of $4.16 and a fifty-two week high of $39.90.

Insider Activity at Nutex Health

In other news, CFO Jon Christian Bates acquired 1,350 shares of Nutex Health stock in a transaction on Thursday, August 22nd. The shares were purchased at an average price of $21.46 per share, with a total value of $28,971.00. Following the acquisition, the chief financial officer now owns 2,277 shares in the company, valued at $48,864.42. This represents a 100.00 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 38.52% of the stock is currently owned by company insiders.

Institutional Trading of Nutex Health

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. International Assets Investment Management LLC bought a new position in shares of Nutex Health in the 3rd quarter valued at about $188,000. Thompson Davis & CO. Inc. bought a new stake in shares of Nutex Health during the third quarter worth approximately $494,000. Finally, Essex Investment Management Co. LLC acquired a new position in Nutex Health in the third quarter valued at approximately $1,579,000. 5.32% of the stock is owned by institutional investors.

Nutex Health Company Profile

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.